Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Perrin Ross

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis International|June 15, 2013
Assessing relapse in multiple sclerosis questionnaire: results of a pilot studyAmy Perrin Ross, Alona Williamson, Jennifer Smrtka, et al.
International Journal of MS Care|September 18, 2023
Factors Associated With Disease-Modifying Therapy Adherence and Persistence in Multiple Sclerosis: A Scoping Literature ReviewAliza Bitton Ben-Zacharia, Bryan Walker, Amy Perrin Ross, et al.
Drugs - Real World Outcomes|September 22, 2023
Analysis of Pregnancy Outcomes Following Exposure to Intramuscular Interferon Beta-1a: The AVONEX<sup>®</sup> Pregnancy Exposure RegistryBianca Weinstock-Guttman, Amy Perrin Ross, Jonathan Planton, et al.
BMC Neurology|January 20, 2025
Real-world satisfaction and experience with injection and autoinjector device for ofatumumab indicated for multiple sclerosisAmy Perrin Ross, Jacqueline Nicholas, Ming-Hui Tai, et al.
Pharmacoeconomics - Open|August 28, 2024
Clinicians' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice ExperimentAlexander Keenan, Chiara Whichello, Hoa H Le, et al.
The Patient|May 15, 2024
Patients' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice ExperimentAlexander Keenan, Chiara Whichello, Hoa H Le, et al.
BMC Neurology|July 11, 2013
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening toolDavid Bates, Jack Burks, Denise Globe, et al.
International Journal of MS Care|January 24, 2014
Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patientsJack Burks, Michael Chancellor, David Bates, et al.
International Journal of MS Care|March 7, 2018
Pregnancy Outcomes from the Branded Glatiramer Acetate Pregnancy DatabaseMagnhild Sandberg-Wollheim, Orit Neudorfer, Augusto Grinspan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 13, 2023
Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosisJohn Kramer, Ralf Linker, David Paling, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis International|June 15, 2013
Assessing relapse in multiple sclerosis questionnaire: results of a pilot studyAmy Perrin Ross, Alona Williamson, Jennifer Smrtka, et al.
International Journal of MS Care|September 18, 2023
Factors Associated With Disease-Modifying Therapy Adherence and Persistence in Multiple Sclerosis: A Scoping Literature ReviewAliza Bitton Ben-Zacharia, Bryan Walker, Amy Perrin Ross, et al.
Drugs - Real World Outcomes|September 22, 2023
Analysis of Pregnancy Outcomes Following Exposure to Intramuscular Interferon Beta-1a: The AVONEX<sup>®</sup> Pregnancy Exposure RegistryBianca Weinstock-Guttman, Amy Perrin Ross, Jonathan Planton, et al.
BMC Neurology|January 20, 2025
Real-world satisfaction and experience with injection and autoinjector device for ofatumumab indicated for multiple sclerosisAmy Perrin Ross, Jacqueline Nicholas, Ming-Hui Tai, et al.
Pharmacoeconomics - Open|August 28, 2024
Clinicians' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice ExperimentAlexander Keenan, Chiara Whichello, Hoa H Le, et al.
The Patient|May 15, 2024
Patients' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice ExperimentAlexander Keenan, Chiara Whichello, Hoa H Le, et al.
BMC Neurology|July 11, 2013
Development of a short form and scoring algorithm from the validated actionable bladder symptom screening toolDavid Bates, Jack Burks, Denise Globe, et al.
International Journal of MS Care|January 24, 2014
Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patientsJack Burks, Michael Chancellor, David Bates, et al.
International Journal of MS Care|March 7, 2018
Pregnancy Outcomes from the Branded Glatiramer Acetate Pregnancy DatabaseMagnhild Sandberg-Wollheim, Orit Neudorfer, Augusto Grinspan, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 13, 2023
Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosisJohn Kramer, Ralf Linker, David Paling, et al.
Pageof 3